ERNA
Eterna Therapeutics Inc
NASDAQ: ERNA · HEALTHCARE · BIOTECHNOLOGY
$0.15
-21.24% today
Updated 2026-04-30
Market cap
$5.59M
P/E ratio
—
P/S ratio
1,275.37x
EPS (TTM)
$-2.24
Dividend yield
—
52W range
$0 – $4
Volume
1.1M
Eterna Therapeutics Inc (ERNA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-687.00%
ROA
-104.90%
Debt/equity
0.15x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $32.98M | $-4.77M | 100.00% | -4.12% | -14.47% |
| 2009 | $25.81M | $-1.50M | 96.44% | -5.81% | -5.81% |
| 2010 | $25.31M | $-400000.00 | 97.37% | -1.28% | -1.58% |
| 2011 | $23.87M | $-3.42M | 96.27% | -13.72% | -14.32% |
| 2012 | $24.06M | $-995000.00 | 97.00% | -4.41% | -4.13% |
| 2013 | $23.75M | $-1.05M | 96.91% | -4.71% | -4.43% |
| 2014 | $26.05M | $-5.03M | 97.68% | -18.21% | -19.31% |
| 2015 | $24.52M | $-7.23M | 46.74% | -26.92% | -29.47% |
| 2016 | $22.31M | $-2.92M | 63.55% | -10.21% | -13.10% |
| 2017 | $21.27M | $-1.08M | 66.68% | -6.59% | -5.06% |
| 2018 | $23.34M | $-259000.00 | 64.07% | 1.99% | -1.11% |
| 2019 | $19.81M | $-2.05M | 60.40% | -6.12% | -10.34% |
| 2020 | $5.80M | $11.91M | -1.69% | -124.97% | 205.28% |
| 2021 | $0.00 | $-122.55M | — | — | — |
| 2022 | $0.00 | $-24.58M | — | — | — |
| 2023 | $68000.00 | $-21.67M | -247.06% | -31,080.88% | -31,864.71% |
| 2024 | $582000.00 | $-44.54M | 83.51% | -2,693.13% | -7,652.75% |
| 2025 | $0.00 | $-14.10M | — | — | — |